B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity: Further evidence that B7-1 and B7-2 are functionally distinct

Journal of Immunology

Volumn 156, Issue 3, 1996, Pages 1126-1131

  Matulonis, Ursula ^a,b   Dosiou, Chrysoula ^a   Freeman, Gordon ^a   Lamont, Clare ^a   Mauch, Peter ^a   Nadler, Lee M ^a   Griffin, James D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; TUMOR VACCINE;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL VIABILITY; CELLULAR IMMUNITY; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOGENICITY; IMMUNOPHENOTYPING; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY; VACCINATION;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CD4-POSITIVE T-LYMPHOCYTES; GRAFT REJECTION; IMMUNOTHERAPY, ADOPTIVE; LEUKEMIA, EXPERIMENTAL; LEUKEMIA, MYELOID; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICE, NUDE; NEOPLASM TRANSPLANTATION; T-LYMPHOCYTES; TUMOR CELLS, CULTURED;

EID: 0030028248     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Boon, T., E. DePlaen, C. Lurquin, B. van den Eynde, P van der Bruygen, C. Traversari, A. Amar-Costesec, and A Van Pel 1992. Identification of tumor rejection antigens recognized by T lymphocytes. Cancer Surv 13:23.
2. Boon, T. P. Coulie, M Marchand, P. Weynants, T. Wolfel, and V. Brichard. 1994. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy. In Important Advances in Oncology 1994 V. T. DeVita, S Hellman, and S. Rosenberg, eds. J. B Lippincott Co., Philadelphia, p. 53
3. Doyle, A., W J. Martin, K. Funa, A. Gazdar, D Carney, S. E. Martin, I Linnoila, F. Cuttitta, J Mulshine, P Bunn, and J. Minna. 1985. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer J. Exp. Med 161.1135.
4. Lassam, N., and G. Jay. 1989 Suppression of MHC class I RNA in highly oncogenic cells occurs at the level of transcription initiation. J. Immunol 143: 3792
5. Chen, L., S. Ashe, W. A. Brady, I. Hellstrom, K. E. Hellstrom, J. A. Ledbetter, P. McGowan, and P S. Linsley. 1992. Costimulation of antitumor immunity by the B7 counter-receptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 71:1093.
6. + T cells by B7-transfected melanoma cells. Science 259:368.
7. Lundberg, A , J Gribben, S. Lazo, and L. Nadler. 1993. Expression and induction of B7 on leukemic cells isolated from patients with hematologic malignancies. Blood 82.123a
8. Matulonis, U., C. Dosiou, C Lamont, G. J Freeman, P. Mauch, L. M. Nadler, and J. D. Griffin 1995. Role of B7-1 in mediating an immune response to myeloid leukemia cells. Blood 85:2507.
9. Baskar, S , S. Ostrand-Rosenberg, N. Nabavi, L. M. Nadler, G J Freeman, and L. H. Glimcher. 1993. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc. Natl. Acad. Sci USA 90:5687.
10. Yang, G., K. E. Hellstrom, I. Hellstrom, and L. Chen. 1995. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules. J. Immunol. 154:2794
11. Freeman, G. J , F. Borriello, R. J. Hodes, H. Reiser, J. G. Gribben, J. W. Ng, J. Kim, J. M. Goldberg, K Hathcock, G. Laszlo, L. A. Lombard, S Wang, G S. Gray, L. M. Nadler, and A. Sharpe. 1993. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production J Exp. Med. 178:2185.
12. Freeman, G J., J. G. Gribben, V A Boussiotis, J. W. Ng, V. Restivo, Jr., L. A. Lombard, G. S. Gray, and L M Nadler. 1993. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation Science 262:909.
13. Thompson, C. B. 1995. Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell 81:979.
14. Kuchroo, V. K., M. P. Das, J. A Brown, A. M. Ranger, S. S. Zamvil, R A Sobel, H. L. Weiner, N. Nabavi, and L. H. Glimcher 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways application to autoimmune disease therapy. Cell 80:707
15. Freeman, G. J., V A Boussiotis, A Anumanthan, G. M. Bernstein, X.-Y. Ke, P. D. Rennert, G. S. Gray, J G. Gribben, and L. M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals since B7-2 but not B7-1 costimulates the initial production of IL-4. Immunity 2:523
16. Greenberger, J. S., M. A. Sakakeeny, R. K. Humphries, C. J. Eaves, and R. J. Eckner 1983. Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor lines. Proc. Natl. Acad. Sci USA 80:2931.
17. Matulonis, U., R Salgia, K. Okuda, B. Druker, and J. D. Griffin 1993 Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line. Exp. Hematol. 21: 1460.
18. Freeman, G. J., G. S Gray, C. D. Gimmi, D. B Lombard, L. J. Zhou, M. White, J. D. Fingeroth, J. G. Gribben, and L M Nadler. 1991. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J. Exp. Med. 174 625
19. Te Riele, H., E. R Maandag, A. Clarke, M. Hooper, and A. Berns. 1990. Consecutive mactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells Nature 348.649.
20. Linsley, P. S , W. Brady, M. Urnes, L S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561.
21. Razi-Wolf, Z., G. J. Freeman, F Galvin, B. Benacerraf, L Nadler, and H. Reiser. 1992. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells Proc. Natl Acad. Sci. USA 89: 4210.
22. Hathcock, K S , G. Laszlo, H. B Dickler, J. Bradshaw, P. Linsley, and R J. Hodes 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation Science 262.905
23. + tumor cells are potent vaccines for stimulating tumor rejection in tumor-bearing mice. J Exp. Med 181. 619